Circulation Journal
Case Report
A Japanese Patient With Cardiomyopathy Caused by a Novel Mutation R285X in the AGL Gene
Akiyoshi OgimotoMinoru OkuboHideki OkayamaYoon S. ShinYoriko EndoTetsu EbaraKatsuji InoueTomoaki OhtsukaHideki TaharaToshio MuraseJistuo Higaki
Author information

Volume 71 (2007) Issue 10 Pages 1653-1656

Download PDF (334K) Contact us

Left ventricular hypertrophy (LVH) is primarily or secondarily caused by a cardiovascular or systemic disease. The pattern of LVH is distinctive in hypertrophic or metabolic cardiomyopathy and differs from that seen in LVH caused by hypertension or aortic stenosis. A 42-year-old Japanese man had LVH similar to that with hypertrophic cardiomyopathy. The patient was diagnosed with glycogen storage disease type IIIa (GSD-IIIa). Echocardiography showed that he had severe LVH, and concomitant hepatomegaly and hypoglycemia, which led to measurement of glycogen debranching enzyme (GDE) activity; it was undetectable. Sequence analysis of the AGL gene encoding GDE showed a novel nonsense mutation: a C-to-T transition at codon 285 in exon 8, resulting in substitution of the arginine codon by the stop codon (R285X). The patient was homozygous for the mutation. Cardiomyopathy in this patient was caused by a nonsense mutation in the AGL gene. Five other Japanese GSD-IIIa patients over 30 years of age have all presented with cardiomyopathy, as well as hepatomegaly and hypoglycemia. Patients with LVH associated with hepatomegaly and hypoglycemia should undergo biochemical and genetic analyses for GSD-IIIa. (Circ J 2007; 71: 1653 - 1656)

Information related to the author
Previous article Next article